Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease

Liver inflammation is greater in nonalcoholic steatohepatitis (NASH) than steatosis, suggesting that immune responses contribute to nonalcoholic fatty liver disease (NAFLD) progression. Livers normally contain many natural killer T (NKT) cells that produce factors that modulate inflammatory and fibrogenic responses. Such cells are relatively depleted in steatosis, but their status in more advanced NAFLD is uncertain. We hypothesized that NKT cells accumulate and promote fibrosis progression in NASH. We aimed to determine if livers become enriched with NKT cells during NASH‐related fibrosis; identify responsible mechanisms; and assess if NKT cells stimulate fibrogenesis. NKT cells were analyzed in wildtype mice and Patched‐deficient (Ptc+/−) mice with an overly active Hedgehog (Hh) pathway, before and after feeding methionine choline‐deficient (MCD) diets to induce NASH‐related fibrosis. Effects of NKT cell‐derived factors on hepatic stellate cells (HSC) were examined and fibrogenesis was evaluated in CD1d‐deficient mice that lack NKT cells. NKT cells were quantified in human cirrhotic and nondiseased livers. During NASH‐related fibrogenesis in wildtype mice, Hh pathway activation occurred, leading to induction of factors that promoted NKT cell recruitment, retention, and viability, plus liver enrichment with NKT cells. Ptc+/− mice accumulated more NKT cells and developed worse liver fibrosis; CD1d‐deficient mice that lack NKT cells were protected from fibrosis. NKT cell‐conditioned medium stimulated HSC to become myofibroblastic. Liver explants were 2‐fold enriched with NKT cells in patients with non‐NASH cirrhosis, and 4‐fold enriched in patients with NASH cirrhosis. Conclusion: Hh pathway activation leads to hepatic enrichment with NKT cells that contribute to fibrosis progression in NASH. (HEPATOLOGY 2010;)

[1]  R. Rippe,et al.  Kupffer cell and interleukin‐12–dependent loss of natural killer T cells in hepatosteatosis , 2010, Hepatology.

[2]  G. Karaca,et al.  Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[3]  B. Gao,et al.  Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases , 2009, Journal of leukocyte biology.

[4]  A. Porrello,et al.  Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production , 2009, Hepatology.

[5]  H. Tilg,et al.  Role for hedgehog pathway in regulating growth and function of invariant NKT cells , 2009, European journal of immunology.

[6]  K. Tsuneyama,et al.  Role of liver-infiltrating CD3+CD56+ natural killer T cells in the pathogenesis of nonalcoholic fatty liver disease , 2009, European journal of gastroenterology & hepatology.

[7]  W. Jeong,et al.  Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride , 2009, Hepatology.

[8]  David H Adams,et al.  Identification of distinct human invariant natural killer T-cell response phenotypes to alpha-galactosylceramide , 2008, BMC Immunology.

[9]  Xiong Ma,et al.  Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. , 2008, Journal of hepatology.

[10]  M. Yeh,et al.  Animal models of NASH: Getting both pathology and metabolic context right , 2008, Journal of gastroenterology and hepatology.

[11]  R. Puri,et al.  Novel Role of IL-13 in Fibrosis Induced by Nonalcoholic Steatohepatitis and Its Amelioration by IL-13R-Directed Cytotoxin in a Rat Model , 2008, The Journal of Immunology.

[12]  D. Schuppan,et al.  Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. , 2008, The Journal of clinical investigation.

[13]  M. Swain.  Hepatic NKT cells: friend or foe? , 2008, Clinical science.

[14]  A. Diehl,et al.  The adventures of sonic hedgehog in development and repair. II. Sonic hedgehog and liver development, inflammation, and cancer. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[15]  Zhigang Tian,et al.  Liver: An organ with predominant innate immunity , 2007, Hepatology.

[16]  J. Sicklick,et al.  Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice , 2007, Laboratory Investigation.

[17]  R. Jhaveri,et al.  Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers , 2007, Laboratory Investigation.

[18]  Albert Bendelac,et al.  The biology of NKT cells. , 2007, Annual review of immunology.

[19]  M. Capron,et al.  Invariant and Noninvariant Natural Killer T Cells Exert Opposite Regulatory Functions on the Immune Response during Murine Schistosomiasis , 2007, Infection and Immunity.

[20]  J. Sicklick,et al.  Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation , 2007, Laboratory Investigation.

[21]  R. Jhaveri,et al.  Endoplasmic reticulum stress, hepatocyte CD1d and NKT cell abnormalities in murine fatty livers. Lab Invest , 2007 .

[22]  M. Taniguchi,et al.  Methods for detection, isolation and culture of mouse and human invariant NKT cells , 2007, Nature Protocols.

[23]  E. Elinav,et al.  Adoptive transfer of regulatory NKT lymphocytes ameliorates non‐alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping , 2006, The Journal of pathology.

[24]  A. Diehl,et al.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease , 2005, Hepatology.

[25]  S. Porcelli,et al.  The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy. , 2005, Immunology letters.

[26]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[27]  C. Day.  Natural history of NAFLD: remarkably benign in the absence of cirrhosis. , 2005, Gastroenterology.

[28]  Mitchell Kronenberg,et al.  Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids , 2005, PLoS biology.

[29]  D. Adams,et al.  CXC Chemokine Ligand 16 Promotes Integrin-Mediated Adhesion of Liver-Infiltrating Lymphocytes to Cholangiocytes and Hepatocytes within the Inflamed Human Liver1 , 2005, The Journal of Immunology.

[30]  K. Ohya,et al.  Contribution of Va24+Vb11+ natural killer T cells in Wilsonian hepatitis , 2005, Clinical and experimental immunology.

[31]  Mitchell Kronenberg,et al.  Toward an understanding of NKT cell biology: progress and paradoxes. , 2005, Annual review of immunology.

[32]  S. Curbishley,et al.  Hepatic Endothelial CCL25 Mediates the Recruitment of CCR9+ Gut-homing Lymphocytes to the Liver in Primary Sclerosing Cholangitis , 2004, The Journal of experimental medicine.

[33]  M. Exley,et al.  To be or not to be NKT: Natural killer T cells in the liver , 2004, Hepatology.

[34]  N. Afdhal,et al.  Hepatic CD1d Expression in Hepatitis C Virus Infection and Recognition by Resident Proinflammatory CD1d-Reactive T Cells1 , 2004, The Journal of Immunology.

[35]  D. Doherty,et al.  NKT Cells from Normal and Tumor-Bearing Human Livers Are Phenotypically and Functionally Distinct from Murine NKT Cells , 2003, The Journal of Immunology.

[36]  K. Tsuneyama,et al.  Accumulating CD57 + CD3 +  natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[37]  A. Diehl,et al.  Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system. , 2002, Gastroenterology.

[38]  M. Kaplan,et al.  Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. , 2002, Gastroenterology.

[39]  A. Diehl,et al.  Altered hepatic lymphocyte subpopulations in obesity‐related murine fatty livers: Potential mechanism for sensitization to liver damage , 2000, Hepatology.

[40]  K. Batts,et al.  Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis , 1999, Hepatology.

[41]  V. Barnaba,et al.  Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis , 1998, European journal of immunology.

[42]  Y. Ueno,et al.  Primary culture of cholangiocytes from normal mouse liver , 1998, In Vitro Cellular & Developmental Biology - Animal.

[43]  M. Scott,et al.  Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.

[44]  M. Kaplan,et al.  Immunoglobulin E Production in the Absence of Interleukin-4-Secreting CD1-Dependent Cells , 1997, Science.

[45]  O. Lantz,et al.  An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans , 1994, The Journal of experimental medicine.

[46]  A. Sher,et al.  Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. , 1994, Journal of immunology.

[47]  P. Greenwel,et al.  Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. , 1991, Laboratory investigation; a journal of technical methods and pathology.